¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"heavy oxygen"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biological oxygen demand
    »ý¹°ÇÐÀû»ê¼Ò¿ä±¸·®
  • compressed oxygen
    ¾ÐÃà»ê¼Ò
  • chemical oxygen demand
    È­ÇÐÀû»ê¼Ò¿ä±¸·®
  • dissolved oxygen
    ¿ëÇØ»ê¼Ò
  • dissolved oxygen determination
    ¿ëÁ¸»ê¼Ò·®ÃøÁ¤, ³ìÀº»ê¼Ò·®ÃøÁ¤
  • fraction of inspired oxygen
    ÈíÀÔ»ê¼Ò³óµµ
  • hemoglobin oxygen saturation
    Çì¸ð±Û·Îºó»ê¼ÒÆ÷È­µµ
  • hyperbaric oxygen
    °í¾Ð»ê¼Ò
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • inspired oxygen fraction
    µé¼û»ê¼ÒºÐÀ², Èí±â»ê¼ÒºÐÀ²
  • liquid oxygen
    ¾×ü»ê¼Ò
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • oxygen
    »ê¼Ò
  • oxygen aeration
    »ê¼ÒÅë±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oxygen aeration
    »ê¼ÒÅë±â
  • oxygen apnea
    »ê¼Ò¹«È£Èí
  • biochemical oxygen demand
    »ý¹°È­ÇÐÀû»ê¼Ò¿ä±¸·®
  • biological oxygen demand
    »ý¹°ÇÐÀû»ê¼Ò¿ä±¸·®
  • chemical oxygen demand
    È­Çлê¼Ò¿ä±¸·®
  • compressed oxygen
    ¾ÐÃà»ê¼Ò
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • oxygen collar
    »ê¼Ò°í¸®
  • oxygen consumption
    »ê¼Ò¼Ò¸ð
  • oxygen content
    »ê¼ÒÇÔÀ¯·®
  • dissolved oxygen
    ¿ëÇØ»ê¼Ò
  • dissolved oxygen determination
    ¿ëÁ¸»ê¼Ò·®ÃøÁ¤, ³ìÀº»ê¼Ò·®ÃøÁ¤
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä·®
  • oxygen debt
    »ê¼ÒºÎä
  • oxygen demand
    »ê¼Ò¿ä±¸·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arterial oxygen tension
    µ¿¸ÆÇ÷ »ê¼ÒºÐ¾Ð
  • arterial-venous oxygen content difference
    µ¿¸Æ-Á¤¸Æ»ê¼Ò¿ëÀûÂ÷ÀÌ
  • arterial-venous oxygen difference
    µ¿¸Æ-Á¤¸Æ »ê¼ÒÂ÷ÀÌ
  • arteriovenous oxygen content difference
    µ¿Á¤¸ÆÇ÷ »ê¼ÒÇÔ·®Â÷
  • arteriovenous oxygen difference
    µ¿Á¤¸ÆÇ÷ »ê¼Ò±³Â÷(¡­úìß«áÈÎòó¬)
  • arteriovenous oxygen tension difference
    µ¿Á¤¸ÆÇ÷ »ê¼ÒºÐ¾ÐÂ÷
  • hyperbaric oxygen
    °í¾Ð»ê¼Ò
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • ideal alveolar oxygen tension
    ÀÌ»ó(Àû)ÆóÆ÷ »ê¼ÒÀå·Â(ìµßÌîÜøËøàß«áÈíåæ³).
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • Heavy chains
    Áß(ñì)¼â
  • Heavy metals
    Á߱ݼÓ(ñìÐÝáÕ)
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
  • heavy (muscular) work
    Áß(±Ù)ÀÛ¾÷(̡˻ËöËâ).
  • heavy chain
    Áß¼â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heavy magnesia
    Áß(ñì)¸¶±×³×½Ã¾Æ.
  • heavy magnesium carbonate
    Áß(ñì)ź»ê¸¶±×³×½·.
  • heavy metal antagonist
    Á߱ݼӱæÇ×¾à(̡˻ËÛ˻̰Ëâ).
  • heavy metal antagonist
    Á߱ݼӱæÇ×¾à(ñìÐÝáÕÑÏù÷å·).
  • heavy metal excretion
    Á߱ݼӹ輳(̡˻ËÛËÑËÛ).
  • heavy metal excretion
    Á߱ݼӹ輳(ñìÐÝáÕÛÉàÜ).
  • heavy metal intoxication
    Á߱ݼÓÁßµ¶(ÊÙÌ¡ËÄ).
  • heavy metal intoxication
    Á߱ݼÓÁßµ¶(¡­ñéÔ¸).
  • heavy metal poisoning
    Á߱ݼÓÁßµ¶(ÊÙÌ¡ËÄ).
  • heavy metal poisoning
    Á߱ݼÓÁßµ¶(¡­ñéÔ¸).
  • heavy oil
    ÁßÀ¯(ñìêú).
  • heavy particle
    ÁßÀÔÀÚ(ñìí£í­).
  • heavy particle
    ÁßÀÔÀÚ
  • heavy solution
    Áß¾×(ñìäû).
  • heavy water
    Áß¼ö(ñìâ©).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cytochrome c : oxygen oxidoreductase
    »çÀÌÅäÅ©·Ò c »ê¼Ò(ß«áÈ) ¿Á½Ãµµ¸®´öÅ×À̽º (ÔÒ) complex IV
  • oxygen
    »ê¼Ò(ß«áÈ)
  • oxygen carrier
    »ê¼Ò ¿î¹Ýü(ß«áÈê¡Úæô÷)
  • oxygen combining power
    »ê¼Ò°áÇÕ´É(úìäûß«áÈÌ¿ùêÒö)
  • oxygen cycle
    »ê¼Òȸ·Î(ß«áÈüÞÖØ)
  • oxygen debt
    »ê¼ÒºÎä(ß«áÈݶóð)
  • oxygen dissociation curve
    »ê¼ÒÇØ¸®°î¼±(ß«áÈú°×îÍØàÊ)
  • oxygen electrode
    »ê¼ÒÀü±Ø(ß«áÈï³Ð¿)
  • oxygen saturation
    »ê¼ÒÆ÷È­(ß«áÈøéûú)
  • oxygen saturation curve
    »ê¼ÒÆ÷È­°î¼±(ß«áÈøéûúÍØàÊ)
  • oxygen transferase
    "»ê¼Ò Æ®·£½ºÆÛ·¹À̽º, »ê¼ÒÀüÀÌÈ¿¼Ò(ß«áÈï®ì¹ý£áÈ)"
  • oxygen transport
    »ê¼Ò¿î¹Ý(ß«áÈê¡Úæ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
QO2 oxygen quotient; oxygen utilization
AH   1) Atrial Hypertrophy
  2) Anti-Hyaluronidase
  3) Amyloid imm...
e Greek letter epsilon; heavy chain of IgE; permittivity; specific absorptivity
Fd the amino-terminal portion of the heavy chain of an immunoglobulin molecule; ferredoxin
FTH ferritin heavy chain; fracture threshold
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HMM Heavy meromyosin
IGH Ig heavy chain
IGH Immunoglobulin Heavy
IGH Immunoglobulin heavy chain
Khc Kinesin heavy chain
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hyperbaric oxygen chamber
    °í¾Ð »ê¼Ò½Ç
    °í¾ÐÀÇ »ê¼Ò¸¦ ÀÌ¿ëÇØ Àú»ê¼ÒÁõÀ» Ä¡·áÇϱâ À§ÇÑ ÀåÄ¡.
  • maximum oxygen consumption
    ÃÖ´ë »ê¼Ò ¼Ò¸ð·®
  • oxygen
    »ê¼Ò
    Æó¿¡¼­ Ç÷·ù·Î µé¾î°¡ »ýüÀÇ ¸ðµç ¼¼Æ÷¿¡ ¿î¹ÝµÇ´Â °¡½º.
  • oxygen affinity
    »ê¼Ò ģȭ¼º
  • oxygen balance
    »ê¼Ò ÆòÇü
  • oxygen carrier
    »ê¼Ò ¿î¹Ýü
  • oxygen coefficient
    »ê¼Ò °è¼ö
  • oxygen demand
    »ê¼Ò ÇÊ¿ä, »ê¼Ò Çʿ䷮, »ê¼Ò ¿ä±¸·®
  • oxygen deprivation
    »ê¼Ò °áÇÌ, »ê¼Ò ºÎÁ·
  • oxygen dissociation curve
    »ê¼Ò ÇØ¸® °î¼±
  • oxygen lack
    »ê¼Ò ºÎÁ·, »ê¼Ò °áÇÌ
  • oxygen poisoning
    »ê¼Ò Áßµ¶, »ê¼Ò Áßµ¶Áõ
    °í³óµµ »ê¼ÒÀÇ Àå±â°£ ÈíÀÔÀ¸·Î »ý±â´Â Æó ½ÇÁúÀÇ ½ÉÇÑ Àå¾Ö.
  • oxygen probe
    »ê¼Ò Žħ
  • oxygen reserve
    »ê¼Ò ¿¹ºñ
  • oxygen saturaon curve
    »ê¼Ò Æ÷È­ °î¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
heavy water most commonly used by cell biologists to stabilise microtubules.
(18 Nov 1997)
immunoglobulins, heavy-chain Major components of immunoglobulin molecules. They are the larger of the two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins. They differ according to the class of ig from which they were isolated, contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kD. One ig molecule comprises two heavy and two light chains.
(12 Dec 1998)
alactic oxygen debt That part of the oxygen debt that is not lactacid oxygen debt; during recovery, stores of ATP and creatine phosphate must be replenished by oxidative metabolism, and a small amount of oxygen is also needed to restore the normal oxyhemoglobin levels throughout the circulating blood.
(05 Mar 2000)
alveolar-arterial oxygen difference The difference or gradient between the partial pressure of oxygen in the alveolar spaces and the arterial blood: P(A-a)02. Normally in young adults this value is less than 20 mm Hg.
See: alveolar gas equation.
(05 Mar 2000)
arteriovenous oxygen difference <physiology> The difference in the oxygen content (in ml per 100 ml blood) between arterial and venous blood.
(05 Mar 2000)
biochemical oxygen demand The amount of oxygen aerobicorganisms need to carry out oxidative metabolism in watercontaining organic matter, such as sewage.
(09 Oct 1997)
carbon-oxygen ligases <enzyme> Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond.
Registry number: EC 6.1
(12 Dec 1998)
carbon-oxygen lyases <enzyme> Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation.
Registry number: EC 4.2
(12 Dec 1998)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
chemical oxygen demand The amount of dissolved oxygen required to combine with chemicals in wastewater. A measure of the oxygen equivalent of that portion of organic matter that is susceptible to oxidation by a strong chemical oxidizing agent.
(05 Dec 1998)
rubredoxin-oxygen oxidoreductase <enzyme> Contains fad and a new type of haem; site of oxygen reduction to water by desulfovibrio gigas coupled with NADH oxidation
Registry number: EC 1.9.3.-
Synonym: rubredoxin oxidase
(26 Jun 1999)
phosphorus-oxygen lyases <enzyme> Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation.
Registry number: EC 4.6
(12 Dec 1998)
critical dissolved oxygen concentration <biology> The minimum concentration of oxygen in the water needed for the growth of a culture which has been submerged, where oxygen is the limiting factor to the growth of the culture.
(09 Oct 1997)
home oxygen therapy A form of oxygen that is typically delivered via nasal cannula. Commonly provided to those with severe heart or lung disease.
See: chronic obstructive pulmonary disease.
(27 Sep 1997)
hyperbaric oxygen High pressure oxygen, oxygen at a pressure greater than 1 atmosphere.
See: hyperbaric oxygenation.
Singlet oxygen, an excited or higher energy form of oxygen characterised by the spin of a pair of electrons in opposite directions, whereas electron spin is unidirectional in normal molecular oxygen Because of its great reactivity, singlet oxygen is a probable intermediate in most photo-oxidation reactions. Although it exists for no more than 0.1 sec, it may react with atmospheric pollutants to foster smog formation and may have harmful biological effects.
Triplet oxygen, the normal unexcited state of O2 in the atmosphere, in which the unpaired pair of electrons are so displaced that their magnetic fields are oriented in the same direction, resulting in paramagnetism; each of the heat-generated spectral lines of such oxygen can be split by a magnetic field into a triplet.
Compare: singlet oxygen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heavy crop
    dzÀÛ
  • heavy date
    (¾ÖÀÎ.¾àÈ¥ÀÚ¿ÍÀÇ)Áß¿äÇÑ µ¥ÀÌÆ®(»ó´ë)
  • heavy earth
    ÁßÅä
  • heavy element
    Áß¿ø¼Ò
  • heavy foot
    °¡¼Ó Æä´ÞÀ» ¼¼°Ô ¹â´Â »ç¶÷;Áú¼öÇÏ´Â »ç¶÷
  • heavy gun
    Á߯÷
  • heavy hydrogen
    Áß¼ö¼Ò
  • heavy industries
    Áß°ø¾÷
  • heavy metal
    Á߱ݼÓ;ÈǸ¢(À¯·Â)ÇÑ »ç¶÷;°­Àû
  • heavy oil
    ÁßÀ¯
  • heavy part
    ¾ÇÀοª
  • heavy petting
    (¼º±³´Â ÇÏÁö ¾Ê´Â)³óÈÄÇÑ ¾Ö¹«
  • heavy rock
    =progressive rock
  • heavy sea
    °Ý¶û
  • heavy sky
    È帰 ÇÏ´Ã
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á